Fresh analysis indicates that people who stop using new GLP-1 drugs like semaglutide or tirzepatide tend to recover shed pounds at a significantly accelerated pace than those who stop traditional diet and exercise programs.
Findings released in a major medical journal points out that while overweight individuals can lose substantial amounts of their total mass while on the medication, the weight returns at an estimated rate of nearly a kilo each month upon discontinuation.
"Individuals buying these drugs should be informed of the potential of rapid weight regain when the treatment ends," stated expert Dr. Susan Jebb.
That rate of recovery means a reversion to pre-treatment mass within about a year and a half.
Weighing Approaches
The study, which looked at 37 of studies involving over 9,000 of patients, contrasted the effects of GLP-1 agonists with conventional dieting.
The team point out that people who shed pounds through diet and exercise generally see a more gradual creep back—around 100 grams monthly—once they finish.
Explaining the Fast Rebound
Doctors suggest the mode of action of the injections accounts for the heightened rebound.
The injections copy a body's own chemical called GLP-1, which moderates hunger.
"Artificially providing GLP-1 concentrations far above than normal could lead to the body to generate a reduced amount of its endogenous hormone, and may also lessen responsiveness to its actions," said Dr. Adam Collins, a nutrition researcher.
"Withdrawal of this GLP-1 'fix' leads to appetite is unsuppressed, making overeating far more likely."
A Lifelong Condition?
The NHS suggest the injections for people with weight-linked health risks, alongside prescribed lifestyle changes.
Professionals say that, given the likelihood of weight regain, the treatment might need to be life-long.
This view is supported by pharmaceutical companies, who note that the results "highlight the chronic character of obesity," similar to managing conditions like high blood pressure.
User Testimonies
Individuals who have come off the medication explain a sudden resurgence of appetite.
"I experienced something that goes on and you're instantly starving," said one woman.
This challenge is compounded if patients have not developed permanent lifestyle or habit changes during treatment.
Growing Interest
Recent estimates indicate that a significant number of adults in the UK have used weight-loss jabs in the last 12 months, with desire continuing to grow.
- Adoption is more common among women than males.
- The 40s and 50s age group shows the greatest usage rates.
- A large proportion access the medications through private prescriptions rather than the NHS.
In conclusion, researchers caution that while GLP-1 drugs are effective agents for shedding pounds, they are not a magic fix and lasting health benefits hinges on integrated lifestyle management.
